| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 0 | 8.594 | 42.388 | 63.687 | 89.495 | 68.184 | 69.996 | 76.748 |
| Total Income - EUR | - | - | 0 | 8.594 | 42.388 | 68.848 | 89.907 | 68.184 | 69.996 | 76.752 |
| Total Expenses - EUR | - | - | 2.787 | 6.545 | 11.625 | 19.308 | 24.245 | 30.727 | 30.102 | 37.274 |
| Gross Profit/Loss - EUR | - | - | -2.787 | 2.049 | 30.763 | 49.539 | 65.662 | 37.457 | 39.894 | 39.478 |
| Net Profit/Loss - EUR | - | - | -2.787 | 1.798 | 29.850 | 49.104 | 64.810 | 36.911 | 39.418 | 37.521 |
| Employees | - | - | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Angioplast Medical Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 549 | 31.899 | 28.707 | 29.410 | 44.428 | 41.754 | 36.467 | 68.938 |
| Current Assets | - | - | 48 | 4.972 | 21.123 | 61.264 | 34.022 | 32.239 | 61.738 | 31.899 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 530 | 531 | 530 | 0 |
| Receivables | - | - | 0 | 6 | 216 | 656 | 1.373 | 1.321 | 10.709 | 11.439 |
| Cash | - | - | 48 | 4.966 | 20.907 | 60.608 | 32.119 | 30.387 | 50.499 | 20.460 |
| Shareholders Funds | - | - | -2.744 | -896 | 28.971 | 77.527 | 65.077 | 36.960 | 75.839 | 98.301 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 3.341 | 37.767 | 20.858 | 13.148 | 13.373 | 37.034 | 22.366 | 2.536 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Angioplast Medical Srl